Medigus Further Strengthens Growth Plans With Appointment of New Senior Executives and Regional Sales Managers
OMER, Israel, August 3, 2015 – Medigus Ltd. (Nasdaq: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technologies, announced the appointment of new senior executives and several U.S. regional sales managers. As previously announced, Doron Birger was appointed to the Board of Directors and Jeremy Starkweather was appointed as the new Vice President of U.S. Sales and Marketing. On August 1st, Gilad Mamlok commenced his engagement as Chief Financial Officer. Medigus also announced the appointment of four new regional sales managers in the U.S., also effective August 1st.
“Medigus is expected to transition from a clinical stage to a commercial stage company this year and we anticipate that the appointment of our newest team members, Doron, Gilad and Jeremy and the new Regional Sales Managers, all of whom come with strong medical device manufacturer backgrounds, will help to ensure that we deliver on our ambitious plans for growth” said Chris Rowland, Chief Executive Officer of Medigus. “Each of these men brings relevant business development, commercialization and leadership skills to Medigus based on years of experience within the medical device space. I envision that we will benefit immediately from their expertise.”
Mr. Doron Birger was appointed to Medigus’ Board of Directors
Doron Birger currently serves as a director of three publicly-traded life sciences companies in Israel (Hadasit Bio-Holdings Ltd., IceCure, and Medical Compression Systems), and as chairman and director of several private companies in the high-technology medical device space. He previously served as director and chairman of the board of Given Imaging, and as Chief Executive Officer of Elron Electronic Industries, Ltd., from 2002 until 2009. For all of these innovative, Israeli-based, medical device companies, he has played in a pivotal role in aligning their strategic direction, clinical and commercial planning.
For additional information about Mr. Birger, please visit: http://www.medigus.com/about-medigus/board-of-directors-home/181-mr-doron-birger.
Mr. Gilad Mamlok commenced in his role as the newly appointed Chief Financial Officer of Medigus
Gilad Mamlok brings over two decades of financial management and business development experience to his new role at Medigus. He previously was at the helm of corporate financial planning, including leading mergers and acquisitions, investor relations and corporate governance, for several public and private medical device and technology companies located in Israel and the U.S. Most recently, he served as Vice President of Finance at Covidien plc, following its acquisition of Given Imaging, where he was Senior Vice President, Global Finance and Accounting since 2005.
For additional information about Mr. Mamlok, please visit: http://www.medigus.com/investor-relations/corporate-governance/management-team/213-gilad-mamlok.
Mr. Jeremy Starkweather joined as Vice President of U.S. Sales and Marketing
Jeremy Starkweather will lead the U.S. commercialization strategy and the national sales team for the Medigus Ultrasonic
Surgical Endostapler (MUSE™) system, the firm’s flagship medical device. Four new regional sales managers were appointed to U.S. sales team:
• Scott Assencoa – Regional Sales Manager, East
• Jason Ylizarde – Regional Sales Manager, West
• Paul Spier – Regional Sales Manager, Midwest
• Ryan Luttrell – Regional Sales Manager, Southeast
Jeremy brings over 15 years of experience in medical device sales and marketing to his new position. Prior to joining Medigus, he led the U.S. launch and commercialization efforts for Xlumena’s AXIOS™ Stent, following his long standing tenure at Boston Scientific, where he held multiple positions in sales, marketing, and market development in the GI Endoscopy division.
For additional information about Mr. Starkweather, please visit: http://www.medigus.com/investor-relations/corporate-governance/management-team/193-jeremy-starkweather.